These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 20721970)
1. Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-κB, and androgen receptor signaling. Deep G; Gangar SC; Oberlies NH; Kroll DJ; Agarwal R Mol Carcinog; 2010 Oct; 49(10):902-12. PubMed ID: 20721970 [TBL] [Abstract][Full Text] [Related]
2. Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway. Deep G; Oberlies NH; Kroll DJ; Agarwal R Oncogene; 2008 Jun; 27(28):3986-98. PubMed ID: 18332867 [TBL] [Abstract][Full Text] [Related]
3. Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells. Deep G; Oberlies NH; Kroll DJ; Agarwal R Carcinogenesis; 2007 Jul; 28(7):1533-42. PubMed ID: 17389612 [TBL] [Abstract][Full Text] [Related]
4. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells. Jin F; Liu X; Zhou Z; Yue P; Lotan R; Khuri FR; Chung LW; Sun SY Cancer Res; 2005 Jul; 65(14):6354-63. PubMed ID: 16024638 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070 [TBL] [Abstract][Full Text] [Related]
6. Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells. Kar S; Palit S; Ball WB; Das PK Apoptosis; 2012 Jul; 17(7):735-47. PubMed ID: 22453599 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of androgen receptors by NaAsO Kim Y; Park SE; Moon JW; Kim BM; Kim HG; Jeong IG; Yoo S; Ahn JB; You D; Pak JH; Kim S; Hwang JJ; Kim CS Prostate; 2017 Jul; 77(10):1128-1136. PubMed ID: 28556958 [TBL] [Abstract][Full Text] [Related]
8. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells. Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210 [TBL] [Abstract][Full Text] [Related]
9. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells. Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503 [TBL] [Abstract][Full Text] [Related]
10. RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model. Thomas-Jardin SE; Dahl H; Kanchwala MS; Ha F; Jacob J; Soundharrajan R; Bautista M; Nawas AF; Robichaux D; Mistry R; Anunobi V; Xing C; Delk NA Prostate; 2020 Feb; 80(2):133-145. PubMed ID: 31730277 [TBL] [Abstract][Full Text] [Related]
11. The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells. Szliszka E; Helewski KJ; Mizgala E; Krol W Int J Oncol; 2011 Oct; 39(4):771-9. PubMed ID: 21743964 [TBL] [Abstract][Full Text] [Related]
12. Alpha-tomatine attenuation of in vivo growth of subcutaneous and orthotopic xenograft tumors of human prostate carcinoma PC-3 cells is accompanied by inactivation of nuclear factor-kappa B signaling. Lee ST; Wong PF; He H; Hooper JD; Mustafa MR PLoS One; 2013; 8(2):e57708. PubMed ID: 23437404 [TBL] [Abstract][Full Text] [Related]
13. Membrane androgen receptor activation triggers down-regulation of PI-3K/Akt/NF-kappaB activity and induces apoptotic responses via Bad, FasL and caspase-3 in DU145 prostate cancer cells. Papadopoulou N; Charalampopoulos I; Anagnostopoulou V; Konstantinidis G; Föller M; Gravanis A; Alevizopoulos K; Lang F; Stournaras C Mol Cancer; 2008 Dec; 7():88. PubMed ID: 19055752 [TBL] [Abstract][Full Text] [Related]
14. Progesterone Receptor Expression in the Benign Prostatic Hyperplasia and Prostate Cancer Tissues, Relation with Transcription, Growth Factors, Hormone Reception and Components of the AKT/mTOR Signaling Pathway. Spirina LV; Kovaleva IV; Usynin EA; Goorbunov AK; Kondakova IV Asian Pac J Cancer Prev; 2020 Feb; 21(2):423-429. PubMed ID: 32102520 [TBL] [Abstract][Full Text] [Related]
15. The andean anticancer herbal product BIRM causes destabilization of androgen receptor and induces caspase-8 mediated-apoptosis in prostate cancer. Shamaladevi N; Araki S; Lyn DA; Ayyathurai R; Gao J; Lokeshwar VB; Navarrete H; Lokeshwar BL Oncotarget; 2016 Dec; 7(51):84201-84213. PubMed ID: 27705939 [TBL] [Abstract][Full Text] [Related]
16. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539 [TBL] [Abstract][Full Text] [Related]
17. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes. Shukla S; Gupta S Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058 [TBL] [Abstract][Full Text] [Related]
18. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells. Kim HR; Park CG; Jung JY Int J Mol Med; 2014 Feb; 33(2):317-24. PubMed ID: 24285354 [TBL] [Abstract][Full Text] [Related]
19. Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells. Deep G; Oberlies NH; Kroll DJ; Agarwal R Int J Cancer; 2008 Jul; 123(1):41-50. PubMed ID: 18435416 [TBL] [Abstract][Full Text] [Related]
20. Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer. Zhu C; Zhu Q; Wu Z; Yin Y; Kang D; Lu S; Liu P J Cell Physiol; 2018 Feb; 233(2):1104-1119. PubMed ID: 28422286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]